TICKERNOMICS Sign up
Last Update: 2024-03-28 02:08:59
STRYKER CORP ( SYK ) https://www.stryker.com
350.26USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
SYK
27.41%
SPY
32.74%
SYK
51.48%
SPY
92.93%
SYK
93.03%
SPY
224.41%
SYK
438.48%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
135747.84
146572.84
0.54
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
42.89
6.62
7.30
1.97
0.91
31.85
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
18.97
63.68
22.45
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.4103
8.21
11.90
1.11
Other Earnings and Cash Flow Stats:
STRYKER CORP ( SYK ) Net Income TTM ($MM) is 3036.00
STRYKER CORP ( SYK ) Operating Income TTM ($MM) is 3662.00
STRYKER CORP ( SYK ) Owners' Earnings Annual ($MM) is 2696.29
STRYKER CORP ( SYK ) Current Price to Owners' Earnings ratio is 42.60
STRYKER CORP ( SYK ) EBITDA TTM ($MM) is 4676.00
STRYKER CORP ( SYK ) EBITDA Margin is 22.45%
Capital Allocation:
STRYKER CORP ( SYK ) has paid 3.20 dividends per share and bought back -1.8 million shares in the past 12 months
STRYKER CORP ( SYK ) has reduced its debt by 3338.0 million USD in the last 12 months
Capital Structure:
STRYKER CORP ( SYK ) Interest-bearing Debt ($MM) as of last quarter is 10901
STRYKER CORP ( SYK ) Annual Working Capital Investments ($MM) are -4956
STRYKER CORP ( SYK ) Book Value ($MM) as of last quarter is 18593
STRYKER CORP ( SYK ) Debt/Capital as of last quarter is 58%
Other Balance Sheet Stats:
STRYKER CORP ( SYK ) has 2971 million in cash on hand as of last quarter
STRYKER CORP ( SYK ) has 7921 million of liabilities due within 12 months, and long term debt 13209 as of last quarter
STRYKER CORP ( SYK ) has 384 common shares outstanding as of last quarter
STRYKER CORP ( SYK ) has 0 million USD of preferred stock value
Academic Scores:
STRYKER CORP ( SYK ) Altman Z-Score is 5.36 as of last quarter
STRYKER CORP ( SYK ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
STRYKER CORP ( SYK ) largest shareholder is Greenleaf Trust owning 18488307 shares at 6475.71 ($MM) value
William E Berry Jr(an insider) Sold 7690 shares of STRYKER CORP ( SYK ) for the amount of $2756711.20 on 2024-03-07
6.47% of STRYKER CORP ( SYK ) is held by insiders, and 80.33% is held by institutions
STRYKER CORP ( SYK ) went public on 1988-02-01
Other STRYKER CORP ( SYK ) financial metrics:
FCF:2783.00
Unlevered Free Cash Flow:8884.00
EPS:7.21
Operating Margin:18.97
Gross Profit Margin:63.68
Div. Payout Ratio%:38.82
Div. Growth YoY%:12.87
Equity Return%:24.59
Beta:1.11
Buffet's Owners Earnings:2696.29
Price to Owner's Earnings:42.60
About STRYKER CORP ( SYK ) :
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.